首页> 美国卫生研究院文献>Frontiers in Pharmacology >Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review
【2h】

Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review

机译:中草药治疗缺血性心脏病的血管生成研究进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ischemic heart disease (IHD) is one of the primary causes of death around the world. Therapeutic angiogenesis is a promising innovative approach for treating IHD, improving cardiac function by promoting blood perfusion to the ischemic myocardium. This treatment is especially important for targeting patients that are unable to undergo angioplasty or bypass surgery. Chinese herbal medicines have been used for more than 2,500 years and they play an important role alongside contemporary medicines in China. Growing evidence in animal models show Chinese herbal medicines can provide therapeutic effect on IHD by targeting angiogenesis. Identifying the mechanism in which Chinese herbal medicines can promote angiogenesis in IHD is a major topic in the field of traditional Chinese medicine, and has the potential for advancing therapeutic treatment. This review summarizes the progression of research and highlights potential pro-angiogenic mechanisms of Chinese herbal medicines in IHD. In addition, an outline of the limitations of Chinese herbal medicines and challenges they face will be presented.
机译:缺血性心脏病(IHD)是世界范围内死亡的主要原因之一。治疗性血管生成是一种治疗IHD的有前途的创新方法,它通过促进血液对缺血性心肌的灌注来改善心脏功能。对于无法进行血管成形术或搭桥手术的患者,这种治疗尤为重要。中草药已经使用了2500多年,并且在中国与现代药物一起发挥着重要作用。动物模型中越来越多的证据表明,中草药可以通过靶向血管生成而对IHD提供治疗作用。识别中草药在IHD中促进血管生成的机制是中医药领域的一个重要课题,具有促进治疗的潜力。这篇综述总结了研究的进展,并重点介绍了中草药在IHD中潜在的促血管生成机制。此外,还将概述中草药的局限性及其面临的挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号